Main Session
Sep
30
QP 40 - Personalized Therapy and Special populations in Head and Neck Cancer
1239 - Stereotactic Ablative Radiotherapy (SABR) for Early Stage Glottic Cancer: A Multi-Institutional Pooled Analysis of Long-Term Efficacy, Toxicity and Voice Outcomes
Presenter(s)
Sympascho Young, MD, BS - UT Southwestern Medical Center; Arthur JE Child Comprehensive Cancer Centre, Dallas; Calgary, TX; AB